Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04358185
Title Itacitinib in Advanced Hepatocellular Carcinoma (JAKaL)
Acronym JAKaL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Imperial College London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Imperial College Healthcare NHS Trust London W12 0HS United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field